Merck’s Keytruda wins FDA approval to treat head and neck cancer

85

Merck & Co Inc said on Tuesday its blockbuster cancer drug Keytruda won approval from the U.S. Food and Drug Administration to treat a type of head and neck cancer.

http://feeds.reuters.com/~r/reuters/healthNews/~3/27vc9j8Vpxc/mercks-keytruda-wins-fda-approval-to-treat-head-and-neck-cancer-idUSKCN1TC17M